Cargando…

Apolipoprotein B in cardiovascular risk assessment

Detalles Bibliográficos
Autores principales:	Ahmad, Maud, Sniderman, Allan D., Hegele, Robert A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	CMA Impact Inc. 2023
Materias:	Practice
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462411/ https://www.ncbi.nlm.nih.gov/pubmed/37640407 http://dx.doi.org/10.1503/cmaj.230048

Ejemplares similares

Physiological Bases for the Superiority of Apolipoprotein B Over Low‐Density Lipoprotein Cholesterol and Non–High‐Density Lipoprotein Cholesterol as a Marker of Cardiovascular Risk
por: Glavinovic, Tamara, et al.
Publicado: (2022)

Age and Cardiovascular Risk Attributable to Apolipoprotein B, Low‐Density Lipoprotein Cholesterol or Non‐High‐Density Lipoprotein Cholesterol
por: Sniderman, Allan D., et al.
Publicado: (2016)

Standardization of Apolipoprotein B, LDL‐Cholesterol, and Non‐HDL‐Cholesterol
por: Contois, John H., et al.
Publicado: (2023)

Cholesteryl Ester Transfer Protein Inhibition Reduces Major Adverse Cardiovascular Events by Lowering Apolipoprotein B Levels
por: Nelson, Adam J., et al.
Publicado: (2022)

Eradicating the Burden of Atherosclerotic Cardiovascular Disease by Lowering Apolipoprotein B Lipoproteins Earlier in Life
por: Robinson, Jennifer G., et al.
Publicado: (2018)

Temporal changes in concentrations of lipids and apolipoprotein B among adults with diagnosed and undiagnosed diabetes, prediabetes, and normoglycemia: findings from the National Health and Nutrition Examination Survey 1988–1991 to 2005–2008
por: Ford, Earl S, et al.
Publicado: (2013)

Sortilin enhances secretion of apolipoprotein(a) through effects on apolipoprotein B secretion and promotes uptake of lipoprotein(a)
por: Clark, Justin R., et al.
Publicado: (2022)

Spectrum of Apolipoprotein AI and Apolipoprotein AII Proteoforms and Their Associations With Indices of Cardiometabolic Health: The CARDIA Study
por: Wilkins, John T., et al.
Publicado: (2021)

Apolipoprotein B-containing lipoproteins and atherosclerotic cardiovascular disease
por: Shapiro, Michael D., et al.
Publicado: (2017)

Apolipoprotein B, Non-HDL Cholesterol, and LDL Cholesterol as Markers for Atherosclerotic Cardiovascular Disease Risk Assessment
por: Yun, Yeo-Min
Publicado: (2023)

Effect of Aerobic Exercise on Risk Factors of Cardiovascular Disease and the Apolipoprotein B / Apolipoprotein A-1 Ratio in Obese Woman
por: Kim, Dae-Young, et al.
Publicado: (2014)

Atherosclerotic cardiovascular disease risk assessment: An American Society for Preventive Cardiology clinical practice statement
por: Wong, Nathan D., et al.
Publicado: (2022)

Effects of apolipoprotein B on lifespan and risks of major diseases including type 2 diabetes: a mendelian randomisation analysis using outcomes in first-degree relatives
por: Richardson, Tom G, et al.
Publicado: (2021)

Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab
por: Hagström, Emil, et al.
Publicado: (2022)

Apolipoprotein B and Cardiovascular Disease: Biomarker and Potential Therapeutic Target
por: Behbodikhah, Jennifer, et al.
Publicado: (2021)

Effects of weight change on apolipoprotein B-containing emerging atherosclerotic cardiovascular disease (ASCVD) risk factors
por: Dansinger, Michael L., et al.
Publicado: (2019)

Alcohol Drinking, Apolipoprotein Polymorphisms and the Risk of Cardiovascular Diseases
por: Ceci, Flavio M., et al.
Publicado: (2021)

Social bias in artificial intelligence algorithms designed to improve cardiovascular risk assessment relative to the Framingham Risk Score: a protocol for a systematic review
por: Garcha, Ivneet, et al.
Publicado: (2023)

Implementing essential interventions for cardiovascular disease risk management in primary healthcare: lessons from Eastern Europe and Central Asia
por: Collins, Dylan, et al.
Publicado: (2020)

Cardiovascular Disease Risk in Children With Chronic Kidney Disease: Impact of Apolipoprotein C-II and Apolipoprotein C-III
por: Chen, Wei-Ling, et al.
Publicado: (2021)

Sick Individuals and Sick Populations by Geoffrey Rose: Cardiovascular Prevention Updated
por: Sniderman, Allan D., et al.
Publicado: (2018)

‘People like you?’: how people with hypertension make sense of future cardiovascular risk—a qualitative study
por: Marshall, Iain J, et al.
Publicado: (2018)

Managing Cardiovascular and Cancer Risk Associated with JAK Inhibitors
por: Yang, Victor, et al.
Publicado: (2023)

A randomised controlled trial of a consumer-focused e-health strategy for cardiovascular risk management in primary care: the Consumer Navigation of Electronic Cardiovascular Tools (CONNECT) study protocol
por: Redfern, Julie, et al.
Publicado: (2014)

Apolipoprotein E: from cardiovascular disease to neurodegenerative disorders
por: Mahley, Robert W.
Publicado: (2016)

Clinical value of chest pain presentation and prodromes on the assessment of cardiovascular disease: a cohort study
por: Robson, John, et al.
Publicado: (2015)

Tool to assess risk of bias in studies estimating the prevalence of mental health disorders (RoB-PrevMH)
por: Tonia, Thomy, et al.
Publicado: (2023)

Conducting School Suicide Risk Assessment in Distance Learning Environments
por: Brock, Stephen E., et al.
Publicado: (2021)

Global genetic diversity of human apolipoproteins and effects on cardiovascular disease risk
por: Zhou, Yitian, et al.
Publicado: (2018)

Dabigatran and apolipoprotein B
por: ten Cate, Hugo
Publicado: (2016)

Naringenin Prevents Dyslipidemia, Apolipoprotein B Overproduction, and Hyperinsulinemia in LDL Receptor–Null Mice With Diet-Induced Insulin Resistance
por: Mulvihill, Erin E., et al.
Publicado: (2009)

Prediction of future cardiovascular disease with an equation to estimate apolipoprotein B in patients with high cardiovascular risk: an analysis from the TNT and IDEAL study
por: Hwang, You-Cheol, et al.
Publicado: (2017)

Both Serum Apolipoprotein B and the Apolipoprotein B/Apolipoprotein A-I Ratio Are Associated with Carotid Intima-Media Thickness
por: Huang, Fei, et al.
Publicado: (2013)

Journey to multimorbidity: longitudinal analysis exploring cardiovascular risk factors and sociodemographic determinants in an urban setting
por: Ashworth, Mark, et al.
Publicado: (2019)

Apolipoprotein C-III reduction in subjects with moderate hypertriglyceridaemia and at high cardiovascular risk
por: Tardif, Jean-Claude, et al.
Publicado: (2022)

The comparative risk of new-onset diabetes after prescription of drugs for cardiovascular risk prevention in primary care: a national cohort study
por: Currie, Olivia, et al.
Publicado: (2013)

Fidelity of primary care nurses’ delivery of a behavioural change intervention enhancing physical activity in patients at risk of cardiovascular disease: an observational study
por: Westland, Heleen, et al.
Publicado: (2021)

Impact of socioeconomic deprivation on screening for cardiovascular disease risk in a primary prevention population: a cross-sectional study
por: Lang, Sarah-Jane, et al.
Publicado: (2016)

Primary care interventions to reduce cardiovascular risk behaviours in adolescents: a protocol for a systematic review
por: Haller, Dagmar M, et al.
Publicado: (2016)

Can doctors and patients correctly estimate cardiovascular risk? A cross-sectional study in primary care
por: Liew, Su May, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_hihbvcnr07e9r147d3koau8608